Novo's India head Vikrant Shrotriya gave the timing on October 15. EU advisers also backed a revised Kyinsu label for type 2 diabetes, with a final EC decision pending.
Recap by typeshit. Full story at AD HOC NEWS.
An endocrinologist gives a general explainer on who these weight loss injections may suit and how they work, aimed at people with obesity or constant hunger.
She says certain foods prompt the gut to release GLP1 and PYY, which she credits with fullness and slower digestion. A recipe post, not drug news.
The Darling Ingredients unit says the supplement ingredient concentrates over ten neurosupportive peptides, with clinical trials planned to start in December.
The plastic surgeon weighs in on semaglutide and other GLP-1 drugs as more patients of every age turn to them for major weight loss.
The FDA plan would let pharmacies compound peptides like BPC-157 under enforcement discretion, even though agency scientists say safety is unproven.
Medscape covers research tying GLP-1 drug use to lower alcohol consumption. Tap through for the study details and what researchers found.
Loading…